ABEONA THERAPEUTICS INC. Cash and Cash Equivalents, Period Increase (Decrease)
ABEONA THERAPEUTICS INC. (ABEO) reported Cash and Cash Equivalents, Period Increase (Decrease) of $68.61 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-03-16
- ABEONA THERAPEUTICS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $81.23M, a 114.00% increase year-over-year.
- ABEONA THERAPEUTICS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$1.78M.
- ABEONA THERAPEUTICS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$4.91M.
- ABEONA THERAPEUTICS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$5.93M.
- ABEONA THERAPEUTICS INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $68.61M, a 136.55% increase from fiscal 2016.
- ABEONA THERAPEUTICS INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $29.00M, a 1.35% increase from fiscal 2015.
- ABEONA THERAPEUTICS INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $28.62M, a 157.91% increase from fiscal 2014.
- ABEONA THERAPEUTICS INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $11.10M, a 39528.57% increase from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $81.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $79.45M derived: sum of 2 quarters · filed 2018-03-16 | $74.54M derived: sum of 3 quarters · filed 2018-03-16 | $68.61M 10-K · filed 2018-03-16 |
| 2017-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$6.69M derived: sum of 2 quarters · filed 2017-11-14 | -$12.62M 10-Q · filed 2017-11-14 | $25.34M derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | -$4.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$10.84M 10-Q · filed 2017-08-14 | $27.12M derived: sum of 3 quarters · filed 2018-03-16 | $24.00M derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-03-31 | -$5.93M 10-Q · filed 2017-05-15 | $32.03M derived: sum of 2 quarters · filed 2018-03-16 | $28.91M derived: sum of 3 quarters · filed 2018-03-16 | $25.82M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-12-31 | $37.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $34.84M derived: sum of 2 quarters · filed 2018-03-16 | $31.75M derived: sum of 3 quarters · filed 2018-03-16 | $29.00M 10-K · filed 2018-03-16 |
| 2016-09-30 | -$3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$6.21M derived: sum of 2 quarters · filed 2017-11-14 | -$8.95M 10-Q · filed 2017-11-14 | -$12.10M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | -$3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$5.83M 10-Q · filed 2017-08-14 | -$8.98M derived: sum of 3 quarters · filed 2017-08-14 | $3.89M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$2.74M 10-Q · filed 2017-05-15 | -$5.89M derived: sum of 2 quarters · filed 2017-05-15 | $6.99M derived: sum of 3 quarters · filed 2017-05-15 | $29.45M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $9.73M derived: sum of 2 quarters · filed 2017-03-30 | $32.19M derived: sum of 3 quarters · filed 2017-03-30 | $28.62M 10-K · filed 2017-03-30 |
| 2015-09-30 | $12.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $35.33M derived: sum of 2 quarters · filed 2016-11-14 | $31.76M 10-Q · filed 2016-11-14 | $43.12M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $22.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $18.89M 10-Q · filed 2016-08-15 | $30.25M derived: sum of 3 quarters · filed 2016-08-15 | $30.36M derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$3.57M 10-Q · filed 2016-05-16 | $7.78M derived: sum of 2 quarters · filed 2016-05-16 | $7.89M derived: sum of 3 quarters · filed 2016-05-16 | $7.65M derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $11.46M derived: sum of 2 quarters · filed 2016-03-30 | $11.22M derived: sum of 3 quarters · filed 2016-03-30 | $11.10M 10-K · filed 2016-03-30 |
| 2014-09-30 | $110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$134.00K derived: sum of 2 quarters · filed 2015-11-16 | -$259.00K 10-Q · filed 2015-11-16 | -$734.00K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | -$244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$369.00K 10-Q · filed 2015-08-14 | -$844.00K derived: sum of 3 quarters · filed 2015-08-14 | -$1.74M derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | -$125.00K 10-Q · filed 2015-05-14 | -$600.00K derived: sum of 2 quarters · filed 2015-05-14 | -$1.50M derived: sum of 3 quarters · filed 2015-05-14 | $249.00K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | -$475.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$1.37M derived: sum of 2 quarters · filed 2015-03-31 | $374.00K derived: sum of 3 quarters · filed 2015-03-31 | $28.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | -$899.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $849.00K derived: sum of 2 quarters · filed 2014-11-14 | $503.00K 10-Q · filed 2014-11-14 | $793.00K derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $1.40M 10-Q · filed 2014-08-14 | $1.69M derived: sum of 3 quarters · filed 2014-08-14 | $1.21M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | -$346.00K 10-Q · filed 2014-05-12 | -$56.00K derived: sum of 2 quarters · filed 2014-05-12 | -$538.00K derived: sum of 3 quarters · filed 2014-05-12 | -$1.31M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$192.00K derived: sum of 2 quarters · filed 2014-03-26 | -$969.00K derived: sum of 3 quarters · filed 2014-03-26 | -$2.06M 10-K · filed 2014-03-26 |
| 2012-09-30 | -$482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$1.26M derived: sum of 2 quarters · filed 2013-11-14 | -$2.35M 10-Q · filed 2013-11-14 | -$1.24M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | -$777.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$1.87M 10-Q · filed 2013-08-14 | -$760.00K derived: sum of 3 quarters · filed 2013-08-14 | -$3.76M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | -$1.09M 10-Q · filed 2013-05-15 | $17.00K derived: sum of 2 quarters · filed 2013-05-15 | -$2.98M derived: sum of 3 quarters · filed 2013-05-15 | -$4.81M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | -$1.89M derived: sum of 2 quarters · filed 2013-03-20 | -$3.71M derived: sum of 3 quarters · filed 2013-03-20 | -$4.57M 10-K · filed 2013-03-20 |
| 2011-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$4.83M derived: sum of 2 quarters · filed 2012-11-14 | -$5.68M 10-Q · filed 2012-11-14 | -$148.00K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | -$1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$2.69M 10-Q · filed 2012-08-14 | $2.85M derived: sum of 3 quarters · filed 2012-08-14 | $1.59M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | -$859.00K 10-Q · filed 2012-05-15 | $4.68M derived: sum of 2 quarters · filed 2012-05-15 | $3.42M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | $4.28M derived: sum of 2 quarters · filed 2012-03-23 | $6.43M 10-K · filed 2012-03-23 | |
| 2010-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $889.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $2.15M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |